| Filed On | Filing |
|---|---|
| 26 Jun 2024 |
8-K/A: Financial Statements and Exhibits
We have audited the consolidated financial statements of Clade Therapeutics, Inc. and its subsidiaries (the Company), which comprise the consolidated balance sheet as of December 31, 2023, and the related consolidated statement of operat... |
| 05 May 2023 |
8-K/A: Departure/Election of Directors or Officers; Compensation
This letter serves as written notice pursuant to Section 8 of the Executive Employment Agreement between you and Century Therapeutics, Inc. (the “Company”) dated May 26, 2021 (the “Employment Agreement”), that your employment with the Co... |
Loading...
